Table 4.

Adverse events = classified as related to the drug, for all patients during the study period

	ASAQ (n = 144)	AL (n = 144)	Total	p value
Asthenia	61 (42.4 %)	13 (9.0 %)	74 (25.7 %)	<0.001
Anorexia	27 (18.8 %)	12 (8.3 %)	39 (13.5 %)	0.010
Vomiting	11 (7.6 %)	10 (6.9 %)	21 (7.3 %)	0.821
Cough	5 (3.5 %)	7 (4.9 %)	12 (4.2 %)	0.555
Abdominal Pain	6 (4.2 %)	2 (1.4 %)	8 (2.8 %)	0.151
Diarrhoea	4 (2.8 %)	2 (1.4 %)	6 (2.1 %)	0.409
Itching	3 (2.1 %)	1 (0.7 %)	4 (1.4 %)	0.314
Nausea	1 (0.7 %)	1 (0.7 %)	2 (0.7 %)	1.000